Purdue University

First-in-class targeted microRNA therapy slows cancer tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...
EurekAlert!

SNU researchers develop micro-shockwave electronic therapy for safe non-invasive treatment of brain disorders

① Non-invasive stimulation: Can induce signals for cell differentiation, proliferation, and regeneration without surgery or incisions. ② Targeted stimulation: Delivers focused stimulation to the ...
GEN

First-in-Class Targeted MicroRNA Therapy Blocks Tumor Growth in Mice

Researchers at Purdue University have developed a new type of cancer therapy that uses a modified microRNA, miR-34a, to block cancer cell division. In preclinical tests in mice, treatment using the ...
Nature

Boron Neutron Capture Therapy

Boron Neutron Capture Therapy (BNCT) is a targeted radiotherapeutic modality that exploits the nuclear reaction between boron-10 and low-energy thermal neutrons. This reaction produces high-linear ...
Nature

Microbeam Radiation Therapy

Microbeam Radiation Therapy (MRT) is an innovative preclinical radiotherapy modality that utilises arrays of synchrotron-generated X‐ray microbeams to deliver extremely high doses with exceptional ...
Labroots

Reaching Precision in Cancer Therapy Through Patient-Derived MicroOrganoSpheres, Flow Cytometry Analysis, and Molecular Profiling

Precision medicine aims to match the right therapy to the right patient at the right time, improving efficacy and reducing side effects. In this webinar, Dr. Hsu discusses his work to develop ...
Purdue University

First-in-class targeted microRNA therapy slows cancer tumor growth

A new therapy for cancer uses microRNA to slow or stop division of cancer cells. (Photo provided by Second Bay Studios) WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University ...